We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Innovaderma Plc | LSE:IDP | London | Ordinary Share | GB00BT9PTW34 | ORD EUR0.10 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 29.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMIDP
RNS Number : 1814M
InnovaDerma PLC
26 July 2017
InnovaDerma PLC
("InnovaDerma" or the "Company")
Allotment of Shares
Further to the announcements made on 2 and 8 May 2017, InnovaDerma (LSE: IDP), a UK developer of life sciences, beauty and personal care products today announces that it has allotted the final consideration of shares to the sellers of Ergon Medical Limited (the "Allottees").
45,249 Ordinary Shares (the "Final Consideration Shares") were allotted as the final consideration of shares to the Allottees following the finalisation of the completion accounts and were allotted at a price of GBP1.6575 per share. These Final Consideration Shares are in addition to the Ordinary Shares previously issued.
6,930 of the Final Consideration Shares have been issued to the Allottees in certificated form and 38,319 of the Final Consideration Shares have been admitted to CREST. The new Ordinary Shares will rank equally in all respects with the Company's existing Ordinary Shares and will be admitted to trading.
Following the issue of the Final Consideration Shares, the total number of Ordinary Shares in issue is 12,614,804. This number may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company.
Further enquiries
Innovaderma +61 (0)3 9111 Haris Chaudhry/Joe Bayer 0071 finnCap Ltd +44 (0) 207 220 Geoff Nash/Giles Rolls/Kate Bannatyne 0500 Tim Redfern/Alice Lane - Corporate www.finncap.com Broking Cardew Group Shan Shan Willenbrock David Roach + 44 (0)20 7930 Joe McGregor 0777
About InnovaDerma
InnovaDerma PLC (LSE: IDP) is an emerging leader specializing in the research, manufacture and marketing of clinically proven products in life sciences, beauty, and personal care products. InnovaDerma has presence in the UK, US, Australia, New Zealand, Philippines, South Africa, Hong Kong, and South Korea.
www.innovaderma.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
IOELLFFVDIIRFID
(END) Dow Jones Newswires
July 26, 2017 09:22 ET (13:22 GMT)
1 Year Innovaderma Chart |
1 Month Innovaderma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
